Post

Roche’s PI3K inhibitor wins FDA priority review for breast cancer

The US Food and Drug Administration (FDA) has granted a priority review for Roche’s inavolisib as a combination therapy with …

ARVO conference unveils positive Vabysmo data

At the Association for Research in Vision and Ophthalmology (ARVO) conference in Seattle, WA, US, discussions included the coverage of …

Leading peptide manufacturers: Custom solutions and quality assurance 

Leading peptide manufacturers: Custom solutions & quality assurance: Introduction  In the realm of biotechnology and pharmaceuticals, peptides play a pivotal role …

BMS secures another EC approval for Opdivo combination

The European Commission (EC) has granted Bristol Myers Squibb (BMS) approval for its Opdivo (nivolumab) combination with gemcitabine and cisplatin …

Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024

Verona Pharma has announced that it is finalising preparations for the potential US launch of ensifentrine in the third quarter …